CytoMed Therapeutics Limited Ordinary Shares
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-09-30 |
|---|---|---|
Revenue | $83 | $81 |
Gross Profit | 82 | 80 |
EBITDA | -549 | -598 |
EBIT | -611 | -663 |
Net Income | -403 | -722 |
Net Change In Cash | 83 | 81 |
Free Cash Flow | -765 | -526 |
Cash | 4,798 | 6,569 |
Basic Shares | 11,539 | 11,540 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $290 | $270 | $84 | $44 |
Gross Profit | 213 | 263 | 81 | 41 |
EBITDA | -2,937 | -1,110 | -1,188 | -728 |
EBIT | -3,015 | -1,402 | -1,432 | -949 |
Net Income | -3,131 | -2,397 | -1,533 | -1,467 |
Net Change In Cash | 290 | 270 | 84 | 44 |
Free Cash Flow | -2,636 | -1,390 | -1,697 | -841 |
Cash | 8,995 | 1,173 | 1,858 | 668 |
Basic Shares | 10,630 | 7,915 | 6,934 | 5,897 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-03-31 | $0 |
2023-12-31 | $0 |
2023-09-30 | -$0.08 |
2023-06-30 | -$0.06 |
